Charles Schwab Investment Management Inc. Trims Stake in Globe Life Inc. (NYSE:GL)

Charles Schwab Investment Management Inc. lowered its stake in shares of Globe Life Inc. (NYSE:GL – Free Report) by 3.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 778,097 shares of the company’s stock after selling 31,526 shares during the quarter. Charles Schwab [...]

featured-image

Charles Schwab Investment Management Inc. lowered its stake in shares of Globe Life Inc. ( NYSE:GL – Free Report ) by 3.

9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 778,097 shares of the company’s stock after selling 31,526 shares during the quarter. Charles Schwab Investment Management Inc.



owned about 0.93% of Globe Life worth $86,773,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Other hedge funds and other institutional investors also recently modified their holdings of the company.

Versant Capital Management Inc increased its stake in shares of Globe Life by 388.0% during the fourth quarter. Versant Capital Management Inc now owns 244 shares of the company’s stock valued at $27,000 after purchasing an additional 194 shares in the last quarter.

Albion Financial Group UT bought a new position in shares of Globe Life during the fourth quarter valued at approximately $28,000. True Wealth Design LLC bought a new position in shares of Globe Life during the third quarter valued at approximately $59,000. Private Trust Co.

NA increased its stake in shares of Globe Life by 67.5% during the third quarter. Private Trust Co.

NA now owns 670 shares of the company’s stock valued at $71,000 after purchasing an additional 270 shares in the last quarter. Finally, Plato Investment Management Ltd bought a new position in shares of Globe Life during the fourth quarter valued at approximately $84,000. Hedge funds and other institutional investors own 81.

61% of the company’s stock. Analyst Upgrades and Downgrades A number of equities analysts have weighed in on the stock. Jefferies Financial Group raised their target price on shares of Globe Life from $107.

00 to $114.00 and gave the company a “hold” rating in a research note on Tuesday, December 10th. Keefe, Bruyette & Woods raised their price target on shares of Globe Life from $137.

00 to $145.00 and gave the company an “outperform” rating in a research report on Wednesday, February 12th. Evercore ISI raised shares of Globe Life from an “in-line” rating to an “outperform” rating and raised their price target for the company from $132.

00 to $143.00 in a research report on Wednesday, January 8th. BMO Capital Markets started coverage on shares of Globe Life in a research report on Thursday, January 23rd.

They set a “market perform” rating and a $114.00 price target for the company. Finally, Morgan Stanley raised their price target on shares of Globe Life from $125.

00 to $126.00 and gave the company an “equal weight” rating in a research report on Friday, February 28th. Five equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock.

Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $135.60. Insider Transactions at Globe Life In other news, CMO Jennifer Allison Haworth sold 9,000 shares of Globe Life stock in a transaction on Monday, January 6th.

The shares were sold at an average price of $112.91, for a total transaction of $1,016,190.00.

Following the transaction, the chief marketing officer now owns 13,485 shares in the company, valued at $1,522,591.35. This trade represents a 40.

03 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink . Also, Director Mark A.

Blinn sold 3,000 shares of Globe Life stock in a transaction on Monday, January 6th. The stock was sold at an average price of $113.23, for a total transaction of $339,690.

00. Following the transaction, the director now owns 5,122 shares in the company, valued at $579,964.06.

This represents a 36.94 % decrease in their position. The disclosure for this sale can be found here .

Insiders have sold 61,338 shares of company stock worth $7,239,630 in the last 90 days. 1.51% of the stock is currently owned by insiders.

Globe Life Trading Down 2.4 % Shares of GL stock opened at $122.51 on Tuesday.

Globe Life Inc. has a 12-month low of $38.95 and a 12-month high of $131.

39. The company has a current ratio of 0.05, a quick ratio of 0.

05 and a debt-to-equity ratio of 0.50. The firm’s 50 day moving average is $120.

09 and its 200 day moving average is $111.64. The stock has a market capitalization of $10.

27 billion, a P/E ratio of 10.25 and a beta of 0.77.

Globe Life ( NYSE:GL – Get Free Report ) last issued its earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.

12 by $0.02. Globe Life had a net margin of 18.

53% and a return on equity of 22.32%. Research analysts expect that Globe Life Inc.

will post 13.87 earnings per share for the current year. Globe Life Increases Dividend The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 1st.

Stockholders of record on Thursday, April 3rd will be paid a dividend of $0.27 per share. This represents a $1.

08 annualized dividend and a dividend yield of 0.88%. The ex-dividend date is Thursday, April 3rd.

This is a boost from Globe Life’s previous quarterly dividend of $0.24. Globe Life’s dividend payout ratio (DPR) is currently 9.

04%. Globe Life Company Profile ( Free Report ) Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

See Also Five stocks we like better than Globe Life How to Calculate Inflation Rate How to Protect Your Portfolio When Inflation Is Rising What is a Stock Market Index and How Do You Use Them? 3 Tech Stocks Defying Sector Weakness and Thriving in 2025 Why Are These Companies Considered Blue Chips? Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter ..